HomeHealthcare & Life SciencesBiotechnology Stargardts Treatment Market

South Korea Stargardts Treatment Market Size & Outlook, 2026-2034


South Korea Stargardts Treatment Market Insights

  • As per Reed Intelligence insights, the South Korea Stargardts Treatment Market stood at USD 34.19 Million in 2025 and is anticipated to grow to USD 90.23 Million by 2034.
  • The South Korea market is expected to advance at a CAGR of 11.34% from 2026 through 2034.
  • In 2025, Gene Therapy accounted for the highest share of the Treatment Type market size.
  • During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative Treatment Type segment.

Other Key Findings


  • In 2025, South Korea represented 0.86% of the overall global Stargardts Treatment Market size.
  • United States is projected to lead the global Stargardts Treatment Market size by 2034.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
  • China is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 667.09 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 34.19 Million
Market Size In 2034 USD 90.23 Million
Largest segment Gene Therapy
Units Revenue in USD Million
CAGR 11.34% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Gene Therapy
  2. Stem Cell Therapy
  3. Pharmacological Therapy
  4. Nutritional and Supportive Therapy
Disease Stage
  1. Early Stage
  2. Intermediate Stage
  3. Advanced Stage
End-Use
  1. Hospitals and Ophthalmology Clinics
  2. Research Institutes
  3. Specialty Eye Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports